Concanamycin A, the Specific Inhibitor of V-ATPases, Binds to the Vo Subunit c

Markus Huss, Gudrun Ingenhorst, Simone König, M. Gaßel, Stefan Dröse, Axel Zeeck, Karlheinz Altendorf, Helmut Wieczorek

Journal of Biological Chemistry · 2002 · 284 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

Vacuolar-type ATPase (V-ATPase) purified from the midgut of the tobacco hornworm Manduca sexta is inhibited 50% by 10 nm of the plecomacrolide concanamycin A, the specific inhibitor of V-ATPases. To determine the binding site(s) of that antibiotic in the enzyme complex, labeling with the semisynthetic 9-O-[p-(trifluoroethyldiazirinyl)-benzoyl]-21,23-dideoxy-23-[125I]iodo-concanolide A (J-concanolide A) was performed, which still inhibits the V-ATPase 50% at a concentration of 15–20 μm. Upon treatment with UV light, a highly reactive carbene is generated from this concanamycin derivative, resulting in the formation of a covalent bond to the enzyme. In addition, the radioactive tracer 125I makes the detection of the labeled subunit(s) feasible. Treatment of the V1/Vo holoenzyme, the Vo complex, and the V-ATPase containing goblet cell apical membranes with concanolide resulted in the labeling of only the proteolipid, subunit c, of the proton translocating Vo complex. Binding of J-concanolide A to subunit c was prevented in a concentration-dependent manner by concanamycin A, indicating that labeling was specific. Binding was also prevented by the plecomacrolides bafilomycin A1 and B1, respectively, but not by the benzolactone enamide salicylihalamide, a member of a novel class of V-ATPase inhibitors. Vacuolar-type ATPase (V-ATPase) purified from the midgut of the tobacco hornworm Manduca sexta is inhibited 50% by 10 nm of the plecomacrolide concanamycin A, the specific inhibitor of V-ATPases. To determine the binding site(s) of that antibiotic in the enzyme complex, labeling with the semisynthetic 9-O-[p-(trifluoroethyldiazirinyl)-benzoyl]-21,23-dideoxy-23-[125I]iodo-concanolide A (J-concanolide A) was performed, which still inhibits the V-ATPase 50% at a concentration of 15–20 μm. Upon treatment with UV light, a highly reactive carbene is generated from this concanamycin derivative, resulting in the formation of a covalent bond to the enzyme. In addition, the radioactive tracer 125I makes the detection of the labeled subunit(s) feasible. Treatment of the V1/Vo holoenzyme, the Vo complex, and the V-ATPase containing goblet cell apical membranes with concanolide resulted in the labeling of only the proteolipid, subunit c, of the proton translocating Vo complex. Binding of J-concanolide A to subunit c was prevented in a concentration-dependent manner by concanamycin A, indicating that labeling was specific. Binding was also prevented by the plecomacrolides bafilomycin A1 and B1, respectively, but not by the benzolactone enamide salicylihalamide, a member of a novel class of V-ATPase inhibitors. Vacuolar-type ATPases (V-ATPases) 1The abbreviations used are: V-ATPase, vacuolar-type ATPase; J-concanolide A, 9-O-[p-(trifluoroethyldiazirinyl)-benzoyl]-21,23-dideoxy-23-[125I]iodo-concanolide A; DCCD, dicyclohexylcarbodiimide; C12E10, polyoxyethylene 10-laurylether; MALDI-MS, matrix-assisted laser desorption ionization-mass spectrometry. are complex, heteromultimeric proteins consisting of a peripheral, catalytic V1 complex and a membrane bound, ion translocating Vo complex. V-ATPases in eukaryotes appear to be exclusive proton pumps that energize intracellular membranes of all cells as well as plasma membranes in a variety of animal cells (1Wieczorek H. Brown D. Grinstein S. Ehrenfeld J. Harvey W.R. Bioessays. 1999; 21: 637-648Google Scholar). V-ATPases play crucial roles for many cellular processes and may also be involved in diseases such as osteoporosis and cancer (2Nishi T. Forgac M. Nat. Rev. Mol. Cell. Biol. 2002; 3: 94-103Google Scholar). More than a decade ago, bafilomycin A1, a plecomacrolide antibiotic containing a 16-membered lactone ring, was reported to be a specific inhibitor of V-ATPases with a K i value of less than 10 nm (3Bowman E.J. Siebers A. Altendorf K. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 7972-7976Google Scholar). A structure-activity study showed that the concanamycins, 18-membered plecomacrolides, exhibit 10-fold lowerK i values and thus are better and more specific inhibitors of V-ATPases than the bafilomycins (4Dröse S. Bindseil K.U. Bowman E.J. Siebers A. Zeeck A. Altendorf K. Biochemistry. 1993; 32: 3902-3906Google Scholar). Kinetic studies of the bovine chromaffin granule V-ATPase provided the first indirect evidence that bafilomycin A1 interacts with the hydrophobic Vo complex (5Hanada H. Moriyama Y. Maeda M. Futai M. Biochem. Biophys. Res. Commun. 1990; 170: 873-878Google Scholar). Direct evidence came from two independent approaches, both using the bovine-coated vesicle V-ATPase (6Crider B.P. Xie X.S. Stone D.K. J. Biol. Chem. 1994; 269: 17379-17381Google Scholar, 7Zhang J.M. Feng Y. Forgac M. J. Biol. Chem. 1994; 269: 23518-23523Google Scholar). First, a latent acid-activated proton conductance of proteoliposomes containing the reconstituted Vo complex could be blocked by 1 nm bafilomycin A1 (6Crider B.P. Xie X.S. Stone D.K. J. Biol. Chem. 1994; 269: 17379-17381Google Scholar). Second, reconstituted vesicles containing the Vo complex added to clathrin-coated vesicles could protect ATP-dependent proton transport from bafilomycin inhibition (7Zhang J.M. Feng Y. Forgac M. J. Biol. Chem. 1994; 269: 23518-23523Google Scholar). Since considerable protection was also achieved by the reconstituted 100-kDa subunit a alone, it was concluded that the binding site for bafilomycin may reside in this subunit. Affinity chromatography of chicken osteoclast V-ATPase using bafilomycin C1-coupled cellulose led to the purification of the holoenzyme (8Rautiala T.J. Koskinen A.M. Vaananen H.K. Biochem. Biophys. Res. Commun. 1993; 194: 50-56Google Scholar). In the presence of 1 mm DCCD the V-ATPase did not bind to the column, indicating that the binding site for bafilomycin is near the binding site(s) for DCCD and may thus be located in the proteolipid, subunit c. However, because DCCD, especially at the rather high concentration of 1 mm, may bind to sites different from that in the proteolipid and may bind not only to carboxyl groups but also to sulfhydryl groups or to tyrosine residues (9Azzi A. Casey R.P. Nalecz M. Biochim. Biophys. Acta. 1984; 768: 209-226Google Scholar), and since the 100-kDa subunit a was not clearly resolved in this study, the bafilomycin binding subunit was still not identified. Strong hints in favor of subunit c representing the bafilomycin binding subunit were provided by recent results from analysis of Neurospora crassa strains, indicating that those with point mutations in subunit c show a higher tolerance to bafilomycin (I50 80–400 nm) compared with the wild type (I50 6.3 nm); interestingly, the tolerance to concanamycin was not changed simultaneously (10Bowman B.J. Bowman E.J. J. Biol. Chem. 2002; 277: 3965-3972Google Scholar). Based on extensive screening studies of systematically modified derivatives of concanamycin, a probe was designed that still inhibits V-ATPase activity and which generates upon UV-irradiation a covalent bond between the inhibitor and the V-ATPase (11Ingenhorst G. Bindseil K.U. Boddien C. Dröse S. Gaβel M. Altendorf K. Zeeck A. Eur. J. Org. Chem. 2001; 23: 4525-4532Google Scholar, 12Dröse S. Boddien C. Gaβel M. Ingenhorst G. Zeeck A. Altendorf K. Biochemistry. 2001; 40: 2816-2825Google Scholar). In the present report we show for the first time that this derivative of concanamycin A, 9-O-[p-(trifluoroethyldiazirinyl)-benzoyl]-21,23-dideoxy-23-[125I]iodo-concanolide A (J-concanolide A), binds only to subunit c of the V-ATPase from tobacco hornworm (M. sexta) midgut. As many as 20 wholeM. sexta midguts were dissected from feeding fifth instar larvae and homogenized in ice-cold buffer A (5 mm Tris-HCl, 250 mm sucrose, 5 mm Pefabloc SC (Biomol), 5 mm Na-EDTA, pH 8.1). After centrifugation of the crude homogenate in a fixed-angle rotor at 12,000 ×gmax for 5 min at 4 °C, the pellet was resuspended in buffer A and centrifuged again. The resulting pellet was resuspended in buffer A and centrifuged in a fixed-angle rotor at 233,000 × gmax for 30 min at 4 °C to yield a final pellet that was solubilized in buffer B (16 mm Tris-HCl, 0.32 mm EDTA, 9.6 mm 2-mercaptoethanol and 0.1% C12E10, pH 8.1) at 4 °C with a detergent to protein ratio of 2:1. After centrifugation in a fixed-angle rotor at 233,000 × gmax for 1 h at 4 °C, the supernatant was layered on a discontinuous sucrose density gradient (3 ml of 40%, 2 ml of 30%, 2 ml of 20%, and 1.6 ml of 10% sucrose (w/v) dissolved in buffer B with 200 mm KCl and a lower detergent concentration of 0.01% C12E10) and centrifuged in a vertical rotor at 339,000 ×gmax for 90 min at 4 °C. The 30% sucrose fraction was diluted 4-fold with buffer C (20 mm Tris-HCl, 9.6 mm 2-mercaptoethanol, 0.01% C12E10, pH 8.1) containing 50 mmNaCl and subjected to anion exchange chromatography using a Mono Q (Amersham Biosciences) column. The V1/Vo ATPase was eluted in a linear salt gradient (50–400 mm NaCl dissolved in buffer C) at NaCl concentrations between 250 and 280 mm. The last step in the purification protocol was gel permeation chromatography on a Superdex 200 column (AmershamBiosciences), which was performed in buffer C containing 150 mm NaCl. The final yield was ∼1 mg of V-ATPase per 20 midguts. For purification of the Vo complex, midguts of larvae starved for 16–20 h were prepared, homogenized, and centrifuged twice as described above. The second pellet was resuspended in a buffer consisting of 5 mm Tris-HCl, 0.8 m KI, 5 mm Na-EDTA, and 5 mm Pefabloc SC (pH 8.1) and incubated for 30 min on ice. Then the sample was diluted with 16 mm Tris-HCl, 0.32 mm EDTA, 9.6 mm2-mercaptoethanol (pH 8.1) to a KI concentration of 40 mmand centrifuged at 233,000 × gmax for 30 min at 4 °C. The pellet was resuspended in the dilution buffer and centrifuged again under the same conditions. The final pellet was solubilized and purified as described above for the V1/Vo ATPase, except for the use of 20% instead of the 30% sucrose fraction after rate zonal centrifugation. The final yield of the preparation was ∼0.5 mg of Vocomplex per 20 midguts. J-concanolide A as well as its125I-labeled form were synthesized as described elsewhere (11Ingenhorst G. Bindseil K.U. Boddien C. Dröse S. Gaβel M. Altendorf K. Zeeck A. Eur. J. Org. Chem. 2001; 23: 4525-4532Google Scholar). Concanamycin A, bafilomycin A1, and bafilomycin B1 were isolated according to published procedures (12Dröse S. Boddien C. Gaβel M. Ingenhorst G. Zeeck A. Altendorf K. Biochemistry. 2001; 40: 2816-2825Google Scholar). Salicylihalamide was a generous gift from M. R. Boyd (National Cancer Institute, MD, USA). To avoid freeze thaw cycles, which have significant influence on the stability of the substances, aliquots of stock solutions in dimethyl sulfoxide were stored at −70 °C and thawed only once immediately before use. The actual concentrations of the stock solutions were determined spectrophotometrically. ATPase assays with a final volume of 160 μl and a pH of 8.1 contained 3–4 μg of protein, 50 mmTris-Mops, 3 mm 2-mercaptoethanol, 1 mmMgCl2, 0.1 mm sodium orthovanadate, 0.5 mm sodium azide, 20 mm KCl, 0.003% C12E10, 20 mm NaCl, and 3 mm Tris-HCl. After 5 min of preincubation at 30 °C with or without inhibitors, 1 mm Tris-ATP was added, and after an additional 2 min the reaction was stopped by placing the reaction tubes in liquid nitrogen. Determination of the produced inorganic phosphate followed the protocol of Wieczorek et al.(13Wieczorek H. Cioffi M. Klein U. Harvey W.R. Schweikl H. Wolfersberger M.G. Methods Enzymol. 1990; 192: 608-616Google Scholar). 20 μg of the samples were incubated with varying concentrations of J-concanolide A in a volume of 30–40 μl for 1 h on ice or 3 min at room temperature and irradiated for 3 min with UV light (366 nm) on ice. After irradiation, 7.5–10 μl of 5-fold sample buffer (14Laemmli U.K. Nature. 1970; 227: 680-685Google Scholar) was added. The mixture was heated for 45 s at 95 °C or 30 min at 40 °C, cooled on ice, and subjected to SDS-PAGE (10–15% T, 3.3% C; (15Ratajczak R. Bot. Acta. 1994; 107: 201-209Google Scholar)) or to Tricine-SDS-PAGE (16.5% T, 3% C separating gel and 10% T, 3% C spacer gel (16Schägger H. v. Jagow G. Anal. Biochem. 1987; 166: 368-379Google Scholar)), followed by Coomassie staining. The gels were either dried on Whatman paper or sealed in plastic wrap before they were exposed to a phosphoscreen for as many as 72 h and analyzed with the aid of a phosphorimager (Molecular Dynamics). After SDS-PAGE of the purified V1/Vo ATPase, the 100-kDa and the 17-kDa Coomassie-stained bands, respectively, were prepared for mass spectrometry in a procedure adapted from Shevchenko et al.(17Shevchenko A. Wilm M. Vorm O. Mann M. Anal. Chem. 1996; 68: 850-858Google Scholar) and Zhang et al. (18Zhang X. Herring C.J. Romano P.R. Szczepaowska J. Brzeska H. Hinnebusch A.G. Qin J. Anal. Chem. 1998; 70: 2050-2059Google Scholar). Briefly, the proteins were digested by trypsin or chymotrypsin in the gel, and the peptides were mapped using MALDI-MS (TofSpec-2E, Micromass Ltd., Manchester, UK). Fifth instar larvae of M. sexta(Lepidoptera, Sphingidae), weighing 6–8 g, were reared under long-day conditions (16 h of light) at 27 °C using a synthetic diet modified according to Bell et al.(19Bell R.A. Borg T.K. Ittycheriah P.I. J. Insect Physiol. 1974; 20: 669-678Google Scholar). The preparation of highly purified goblet cell apical membranes followed published protocols (13Wieczorek H. Cioffi M. Klein U. Harvey W.R. Schweikl H. Wolfersberger M.G. Methods Enzymol. 1990; 192: 608-616Google Scholar, 20Cioffi M. Wolfersberger M.G. Tissue & Cell. 1983; 15: 781-803Google Scholar). SDS-PAGE, Western blotting on nitrocellulose membranes, and immunostaining were performed as described previously (13Wieczorek H. Cioffi M. Klein U. Harvey W.R. Schweikl H. Wolfersberger M.G. Methods Enzymol. 1990; 192: 608-616Google Scholar, 21Wieczorek H. Putzenlechner M. Zeiske W. Klein U. J. Biol. Chem. 1991; 266: 15340-15347Google Scholar). The unequivocal assignment of an inhibitor such as concanamycin or bafilomycin to a special V-ATPase subunit requires experimental evidence for the existence of all constitutive subunits in the V-ATPase preparation used. Although nearly all subunits of the insect V-ATPase have been cloned and sequenced (22Wieczorek H. Grüber G. Harvey W.R. Huss M. Merzendorfer H. J. Bioenerg. Biomembr. 1999; 31: 67-74Google Scholar, 23Merzendorfer H. Reineke S. Zhao X.F. Jacobmeier B. Harvey W.R. Wieczorek H. Biochim. Biophys. Acta. 2000; 25: 369-379Google Scholar), we had so far not been able to identify the 100-kDa subunit a of the insect V-ATPase unequivocally (24Schweikl H. Klein U. Schindlbeck M. Wieczorek H. J. Biol. Chem. 1989; 264: 11136-11142Google Scholar, 25Wieczorek H. J. Exp. Biol. 1992; 172: 335-343Google Scholar, 26Merzendorfer H. Huss M. Schmid R. Harvey W.R. Wieczorek H. J. Biol. Chem. 1999; 274: 17372-17378Google Scholar). Because this subunit on the one hand appeared to be very sensitive to proteolysis (27Adachi I. Arai H. Pimental R. Forgac M. J. Biol. Chem. 1990; 265: 960-966Google Scholar), and on the other hand was proposed to be a candidate for bafilomycin binding (7Zhang J.M. Feng Y. Forgac M. J. Biol. Chem. 1994; 269: 23518-23523Google Scholar), we repeatedly modified purification protocols to recover a putative subunit a, also in the insect V-ATPase. Degradation during the process of purification was evidently not responsible for our lack of evidence because even with complex cocktails of protease inhibitors we were not able to resolve subunit a (28Wieczorek H. Grüber G. Harvey W.R. Huss M. Merzendorfer H. Zeiske W. J. Exp. Biol. 2000; 203: 127-135Google Scholar). Purification of the M. sexta V-ATPase according to a new protocol as compared with previous procedures (Ref. 24Schweikl H. Klein U. Schindlbeck M. Wieczorek H. J. Biol. Chem. 1989; 264: 11136-11142Google Scholar, see under “Experimental Procedures”) resulted, mainly because of the presence of 200 mm KCl during zonal centrifugation of the detergent-solubilized protein in a sucrose gradient, for the first time in the detection of a 100-kDa subunit in an insect V-ATPase preparation (Fig. 1, lane 3). The 100-kDa band reacted in immunoblots with polyclonal antibodies to the 116-kDa subunit a of the V-ATPase from bovine chromaffin granules (Ref. 29Gillespie J. Ozanne S. Tugal B. Percy J. Warren M. Haywood J. Apps D. FEBS Lett. 1991; 282: Scholar, not but see the results for the the existence of a 100-kDa subunit a, also in sexta midgut V-ATPase. evidence had been provided by the of at two a V-ATPase subunit a in the midgut H. Reineke S. Zhao X.F. Jacobmeier B. Harvey W.R. Wieczorek H. Biochim. Biophys. Acta. 2000; 25: 369-379Google Scholar). that the 100-kDa band the V-ATPase subunit a was from A of peptides were in the of the protein A), 23Merzendorfer H. Reineke S. Zhao X.F. Jacobmeier B. Harvey W.R. Wieczorek H. Biochim. Biophys. Acta. 2000; 25: 369-379Google with of subunits a and c, indicating peptides by A, subunit a subunit c a, subunit and peptides after of the 100-kDa band and the 17-kDa respectively, by MALDI-MS are in Purification of the Vo complex was by the that goblet cell apical membranes of or M. sexta larvae of V1 by from the the Vo membrane Klein U. D. Wieczorek H. J. Biol. Chem. Scholar, R. Harvey W.R. Wieczorek H. J. Biol. Chem. 1996; Scholar). treatment of the membranes with R. A. Harvey W.R. Wieczorek H. J. Biol. Chem. 1994; 269: Scholar) the of to of the Vo complex appeared to of protein with of and (Fig. 1, lane could be as by Western with specific antibodies the Vo subunits a, and (Fig. 1, or by of subunit c (Fig. 1, lane The fifth band with an mass of was sequenced and appeared to be a of subunit c not J-concanolide A (Fig. was synthesized as described elsewhere (11Ingenhorst G. Bindseil K.U. Boddien C. Dröse S. Gaβel M. Altendorf K. Zeeck A. Eur. J. Org. Chem. 2001; 23: 4525-4532Google Scholar). of this inhibitor appeared to be for the of the plecomacrolide binding First, at after treatment with UV light, a highly reactive which be covalent especially Second, the 125I at of the could be used as a radioactive thus detection of the labeled subunit by labeling we the of J-concanolide A on the activity of the V-ATPase As in J-concanolide A inhibited the purified V-ATPase at a concentration of 15–20 to an value of per mg of value was higher than that for the plecomacrolides concanamycin A and bafilomycin A1 and B1, respectively, and the benzolactone enamide of inhibited sexta V-ATPase at with values of ∼0.5 per mg and with concentrations of 10 Although J-concanolide A was of less it still was an inhibitor with an value to that of for bafilomycins (4Dröse S. Bindseil K.U. Bowman E.J. Siebers A. Zeeck A. Altendorf K. Biochemistry. 1993; 32: 3902-3906Google Scholar). UV of the purified M. sexta V-ATPase in the presence of J-concanolide A after SDS-PAGE, Coomassie and of the gel to the detection of 125I at the of the V-ATPase subunit c The of the band as subunit c was by of and peptides resulted in a of with subunit c (Fig. 2 K. 1992; with However, two of and respectively, were not by the of subunit c. from an of the c which is present in V-ATPases of other (2Nishi T. Forgac M. Nat. Rev. Mol. Cell. Biol. 2002; 3: 94-103Google Scholar) but so far could not be in M. the one had that is only one for subunit c in M. but on the other had two K. 1992; Scholar). The may be as a in favor of a labeling of the band representing subunit c a putative was specific because it was on the concentration of J-concanolide A (Fig. 5 A) and because labeling with 10 J-concanolide A was prevented by preincubation with concentrations of concanamycin A from 1 to (Fig. 5 5 B that a concentration of 1 concanamycin was not to J-concanolide A. first this may appear because at a concentration of 0.1 the V-ATPase activity was inhibited nearly However, one to in that the binding of one of concanamycin A to one of the subunits c in a Vo complex may to inhibition of enzyme of concanamycin A be for of J-concanolide A. To the between inhibition and labeling by J-concanolide A, we the Coomassie-stained of subunit c from the SDS-PAGE gel and in a a concentration-dependent between and inhibition of the enzyme activity was of the holoenzyme subunit c evidently was specific for plecomacrolides, because it was also prevented by bafilomycin A1 and B1, (Fig. 5 that the binding site for both of plecomacrolide concanamycin and the in in subunit c. we the between this and the results with crassa which a higher tolerance to bafilomycin but not to concanamycin (10Bowman B.J. Bowman E.J. J. Biol. Chem. 2002; 277: 3965-3972Google Scholar). Because labeling was not by salicylihalamide, we that the site(s) and of inhibition for benzolactone may be different from that for between inhibition of V-ATPase activity by J-concanolide A and of subunit c from the gel in 5 A were The were in a and compared with the enzyme The was by using an gel to the lane with the concentration of J-concanolide A The of the band was to In we in to the purified holoenzyme, the purified Vo complex and highly purified goblet cell apical membranes in which the V-ATPase is the protein in labeling of subunit c was again for the Vo complex as well as for the goblet cell apical we provided for the first time that subunit c, which the of the proton translocating Vo complex of the binding site for plecomacrolide more the site of covalent are in G. and for preparation of samples for mass spectrometry. S. the use of the mass of the protein of D. K. Apps of of for with polyclonal antibodies to the 116-kDa subunit a of the V-ATPase from bovine chromaffin

References

29